NanoString Says Doubled Award Would Be 'Death Sentence'
IP Law 360
JANUARY 18, 2024
Seattle biotech NanoString Technologies Inc. has told a Delaware court that if rival 10x Genomics' request to double a $31 million award in a jury's November finding of willful infringement is granted, it could bankrupt the company and cause harm to both patients and the general public.
Let's personalize your content